临床试验/NCT03667417

NCT03667417招募中不适用

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

Institut Paoli-Calmettes1 个研究点分布在 1 个国家目标入组 5,000 人开始时间: 1999年10月15日最近更新: 2020年7月1日

适应症

试验速览

阶段: 不适用
状态: 招募中
发起方
入组人数: 5,000
试验地点: 1
主要终点: Incidence of breast and / or ovarian cancer during subject lifetime

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

详细描述

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 是

入选标准

未提供

排除标准

•A person of legal age subject to a legal protection measure, or unable to express consent.
•Impossibility to submit to the follow-up of the test for geographical, social or psychological reasons

结局指标

主要结局

Incidence of breast and / or ovarian cancer during subject lifetime

时间窗: 10 years

risk that a subject with a mutation develops breast and / or ovarian cancer during his lifetime, assessed by epidemiologic questionnaires (carcinologic events).

次要结局

未报告次要终点

研究者

发起方

Institut Paoli-Calmettes

申办方类型

Other

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

已完成

不适用

Lessons Learned From the Family Gene ToolkitWomen With BRCA 1 or BRCA 2 MutationNon-tested Female Family Members

NCT02154633University of Michigan13

已完成

不适用

Feasibility of Lifestyle Intervention in BRCA1/2 Mutation CarriersHereditary Breast and Ovarian Cancer

NCT02087592Technical University of Munich69

Unknown

不适用

BRCA Main Home Nutritional Intervention-random StudyBRCA1 MutationBRCA2 Mutation

NCT03570125Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo300

撤回

不适用

Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation CarriersBRCA1 Mutation CarrierBRCA2 Mutation CarrierBreast Carcinoma

NCT00899145Gynecologic Oncology Group

招募中

不适用

Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic EvaluationBRCA-Associated Breast Carcinoma

NCT05763472Fondazione Policlinico Universitario Agostino Gemelli IRCCS10